Cox proportional hazards models of all-cause and cardiovascular mortality according to glycaemia status.
| . | All-cause mortality . | Cardiovascular mortality . | ||||||
|---|---|---|---|---|---|---|---|---|
| . | Unadjusted analysis . | Adjusted analysis . | Unadjusted analysis . | Adjusted analysis . | ||||
| . | HR (95% CI) . | p-value . | HR (95% CI) . | p-value . | HR (95% CI) . | p-value . | HR (95% CI) . | p-value . |
| Normoglycaemia | 1 (reference) | – | 1 (reference) | – | 1 (reference) | – | 1 (reference) | – |
| Prediabetes | 3.8 (1.6–8.8) | 0.002 | 2.6 (1.1–6.3) | 0.040 | 4.2 (1.6–10.9) | 0.003 | 2.9 (1.1–7.9) | 0.041 |
| T2DM | 6.7 (1.1–15.9) | 0.032 | 5.3 (1.7–15.3) | 0.023 | 16.5 (2.2–76.2) | 0.016 | 9.7 (2.9–36.7) | 0.018 |
| . | All-cause mortality . | Cardiovascular mortality . | ||||||
|---|---|---|---|---|---|---|---|---|
| . | Unadjusted analysis . | Adjusted analysis . | Unadjusted analysis . | Adjusted analysis . | ||||
| . | HR (95% CI) . | p-value . | HR (95% CI) . | p-value . | HR (95% CI) . | p-value . | HR (95% CI) . | p-value . |
| Normoglycaemia | 1 (reference) | – | 1 (reference) | – | 1 (reference) | – | 1 (reference) | – |
| Prediabetes | 3.8 (1.6–8.8) | 0.002 | 2.6 (1.1–6.3) | 0.040 | 4.2 (1.6–10.9) | 0.003 | 2.9 (1.1–7.9) | 0.041 |
| T2DM | 6.7 (1.1–15.9) | 0.032 | 5.3 (1.7–15.3) | 0.023 | 16.5 (2.2–76.2) | 0.016 | 9.7 (2.9–36.7) | 0.018 |
HR: hazard ratio; CI: confidence interval; T2DM: type 2 diabetes mellitus
Cox proportional hazards models of all-cause and cardiovascular mortality according to glycaemia status.
| . | All-cause mortality . | Cardiovascular mortality . | ||||||
|---|---|---|---|---|---|---|---|---|
| . | Unadjusted analysis . | Adjusted analysis . | Unadjusted analysis . | Adjusted analysis . | ||||
| . | HR (95% CI) . | p-value . | HR (95% CI) . | p-value . | HR (95% CI) . | p-value . | HR (95% CI) . | p-value . |
| Normoglycaemia | 1 (reference) | – | 1 (reference) | – | 1 (reference) | – | 1 (reference) | – |
| Prediabetes | 3.8 (1.6–8.8) | 0.002 | 2.6 (1.1–6.3) | 0.040 | 4.2 (1.6–10.9) | 0.003 | 2.9 (1.1–7.9) | 0.041 |
| T2DM | 6.7 (1.1–15.9) | 0.032 | 5.3 (1.7–15.3) | 0.023 | 16.5 (2.2–76.2) | 0.016 | 9.7 (2.9–36.7) | 0.018 |
| . | All-cause mortality . | Cardiovascular mortality . | ||||||
|---|---|---|---|---|---|---|---|---|
| . | Unadjusted analysis . | Adjusted analysis . | Unadjusted analysis . | Adjusted analysis . | ||||
| . | HR (95% CI) . | p-value . | HR (95% CI) . | p-value . | HR (95% CI) . | p-value . | HR (95% CI) . | p-value . |
| Normoglycaemia | 1 (reference) | – | 1 (reference) | – | 1 (reference) | – | 1 (reference) | – |
| Prediabetes | 3.8 (1.6–8.8) | 0.002 | 2.6 (1.1–6.3) | 0.040 | 4.2 (1.6–10.9) | 0.003 | 2.9 (1.1–7.9) | 0.041 |
| T2DM | 6.7 (1.1–15.9) | 0.032 | 5.3 (1.7–15.3) | 0.023 | 16.5 (2.2–76.2) | 0.016 | 9.7 (2.9–36.7) | 0.018 |
HR: hazard ratio; CI: confidence interval; T2DM: type 2 diabetes mellitus
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
